Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.3%
Wed, 25 Sep 9:28

PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.3%Image source: phive2015/www.istockphoto.com

PIRAMAL PHARMA share price has zoomed 6% and is presently trading at Rs 230.3.

Meanwhile, the BSE HEALTHCARE index is at 44,081.5 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Sanofi India (up 0.7%) and GLAND PHARMA (up 0.7%).

ASTRAZENECA PHARMA (down 5.3%) and MAX HEALTHCARE INSTITUTE (down 4.7%) are among the top losers today.

Over the last one year, PIRAMAL PHARMA has moved up from Rs 97.0 to Rs 230.3, registering a gain of Rs 133.4 (up 137.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 44,081.5, registering a gain of 58.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 181.6%), SUVEN PHARMACEUTICALS (up 126.1%) and Glenmark Pharma (up 115.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 84,903.9 .

The top losers among the BSE Sensex today are Asian Paints (down 0.7%) and Nestle (down 0.6%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.

In the meantime, NSE Nifty is at 25,940.5 . TATA STEEL 2% CCPS and LTIMINDTREE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 84,903.9, registering a gain of 18,880.2 points (up 28.6%).

PIRAMAL PHARMA Financial Update...

PIRAMAL PHARMA net profit grew 1.7% YoY to Rs -1,110 million for the quarter ended June 2024, compared to a loss of Rs 1,130 million a year ago. Net sales rose 11.6% to Rs 19,511 million during the period as against Rs 17,489 million in April-June 2023.

For the year ended March 2024, PIRAMAL PHARMA reported 109.6% increase in net profit to Rs 178 million compared to net loss of Rs 1,865 million during FY23. Revenue of the company grew 15.4% to Rs 81,712 million during FY24.

The current Price to earnings ratio of PIRAMAL PHARMA, based on rolling 12 month earnings, stands at -768.4.


Equitymaster requests your view! Post a comment on "PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.3%". Click here!